Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>BIOKIN Delays HK Listing; IPO Originally Scheduled to Close Tdy
Recommend 14 Positive 7 Negative 15 |
||||
|
||||
|
BIOKIN (02615.HK), a Chinese biopharmaceutical company whose IPO is originally scheduled to close at noon today, announced that, in light of the prevailing market conditions and having consulted with the overall coordinators, it has decided that the global offering will be postponed and will not proceed pursuant to the prospectus. Accordingly, the international underwriting agreement relating to the international offering will not be entered into, and the Hong Kong underwriting agreement relating to the Hong Kong public offering will therefore not become unconditional. BIOKIN and the overall coordinators are carefully assessing an updated timetable in relation to the global offering and the listing. Application funds will be refunded next Monday (November 17). AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
